Application Sponsors
| ANDA 214745 | FRESENIUS KABI USA |  | 
Marketing Status
Application Products
| 001 | INJECTABLE;INJECTION | 10MG/2ML (5MG/ML) | 0 | DIAZEPAM | DIAZEPAM | 
FDA Submissions
| UNKNOWN;  | ORIG | 1 | AP | 2022-11-10 | STANDARD  | 
Submissions Property Types
TE Codes
CDER Filings
FRESENIUS KABI USA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 214745
            [companyName] => FRESENIUS KABI USA
            [docInserts] => ["",""]
            [products] => [{"drugName":"DIAZEPAM","activeIngredients":"DIAZEPAM","strength":"10MG\/2ML (5MG\/ML)","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"11\/10\/2022","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2022-11-10
        )
)